Andrea Moir

IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies.

M. Jamei, L. Aarons, M. Bolger, 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Bridging in vitro dissolution and in vivo exposure for acalabrutinib. Part II. A mechanistic PBPK model for IR formulation comparison, proton pump inhibitor drug interactions, and administration with acidic juices.

C. Krejsa, A. P. Plumb, Ric Barker, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Physiologically Based Biopharmaceutics Model for Selumetinib Food Effect Investigation and Capsule Dissolution Safe Space – Part I: Adults

X. Pepin, Maria Hammarberg, Alexandra Mattinson, 2022, Pharmaceutical Research.

Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series

Andreas M. Abend, B. Griffin, Diansong Zhou, 2022, Pharmaceutics.

Impact of acid-reducing agents on gastrointestinal physiology and design of biorelevant dissolution tests to reflect these changes.

J. Dressman, D. Carlile, Eva M. Karlsson, 2019, Journal of pharmaceutical sciences.

Prediction of plasma profiles of a weakly basic drug after administration of omeprazole using PBPK modeling.

J. Dressman, Eva M. Karlsson, J. Mann, 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Challenges and Strategies for Solubility Measurements and Dissolution Method Development for Amorphous Solid Dispersion Formulations

B. Hens, Johanna Milsmann, Hanlin Li, 2022, The AAPS Journal.

Acalabrutinib Maleate Tablets: The Physiologically Based Biopharmaceutics Model behind the Drug Product Dissolution Specification.

X. Pepin, J. Mann, Andrea Moir, 2023, Molecular pharmaceutics.

Biorelevant in vitro tools and in silico modelling to assess pH-dependent drug-drug interactions for salts of weak acids: case example potassium raltegravir.

J. Dressman, Eva M. Karlsson, J. Mann, 2021, Journal of pharmaceutical sciences.

Evaluating the impact of acid-reducing agents on drug absorption using biorelevant in vitro tools and PBPK modeling - Case example dipyridamole.

J. Dressman, S. Arora, Ric Barker, 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Streamlining Food Effect Assessment — Are Repeated Food Effect Studies Needed? An IQ Analysis

T. Heimbach, S. Vaidhyanathan, F. Kesisoglou, 2023, The AAPS Journal.